What are the Treatment Options for EML4-ALK Positive Cancers?
Patients with EML4-ALK positive cancers often benefit from targeted therapies known as ALK inhibitors. Some of the commonly used ALK inhibitors include crizotinib, ceritinib, alectinib, and lorlatinib. These drugs specifically target the abnormal ALK protein, inhibiting its activity and slowing down cancer progression.
